| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |